Shiraz Institute for Cancer ResearchIranian Journal of Immunology1735-13839420121201An Endogenous Immune Adjuvant Released by Necrotic Cells for Enhancement of DNA Vaccine Potency21522516874ENRohollahDorostkarDepartment of Virology, Faculty of Medical Sciences, Tarbiat Modares University, TehranTaravatBamdadDepartment of Virology, Faculty of Medical Sciences, Tarbiat Modares University, TehranMasoudParsaniaDepartment of
Microbiology, Tehran Medical Branch, Islamic Azad University, Tehran, IranHassanPouriayevaliDepartment of Virology, Faculty of Medical Sciences, Tarbiat Modares University, TehranJournal Article20160805<b>Background</b>: Improving vaccine potency in the induction of a strong cell-mediated cytotoxicity can enhance the efficacy of vaccines. Necrotic cells and the supernatant of necrotic tumor cells are attractive adjuvants, on account of their ability to recruit antigen-presenting cells to the site of antigen synthesis as well as its ability to stimulate the maturation of dendritic cells. <br/><b>Objective</b>: To evaluate the utility of supernatant of necrotic tumor cells as a DNA vaccine adjuvant in a murine model. <br/><b>Method</b>: The supernatant of EL4 necrotic cells was co-administered with a DNA vaccine expressing the glycoprotein B of Herpes simplex virus-1 as an antigen model under the control of Cytomegalovirus promoter. C57BL/6 mice were vaccinated three times at two weeks intervals with glycoprotein B DNA vaccine and supernatant of necrotic EL4 cells. Five days after the last immunization, cell cytotoxicity, IFN-γ and IL-4 were evaluated. <br/><b>Results</b>: The obtained data showed that the production of IFN-γ from the splenocytes after antigenic stimulation in the presence of the supernatant of necrotic EL4 cells was significantly higher than the other groups (p<0.002). The flow cytometry results showed a significant increase in the apoptosis/necrosis of EL4 cells in the mice immunized with DNA vaccine and supernatant of necrotic EL4 cells comparing to the other groups (p<0.001). <br/><b>Conclusion</b>: The supernatant of necrotic cells contains adjuvant properties that can be considered as a candidate for tumor vaccination.Shiraz Institute for Cancer ResearchIranian Journal of Immunology1735-13839420121201CCL22 16C/A Genetic Variation is not Associated with Breast Carcinoma in Southern Iranian Population22623316875ENNasrollahErfaniCancer Immunology Research Group, Shiraz Institute for Cancer Research, School of Medicine, Shiraz
University of Medical Sciences, Shiraz0000-0002-4158-9128FaezehMoghaddasi-SaniDepartment of Biology, Faculty of Sciences, Islamic Azad
University-Science and Research Branch, TehranMahboubehRazmkhahCancer Immunology Research Group, Shiraz Institute for Cancer Research, School of Medicine, Shiraz
University of Medical Sciences, ShirazMohammad RezaHaghshenasCancer Immunology Research Group, Shiraz Institute for Cancer Research, School of Medicine, Shiraz
University of Medical Sciences, ShirazAbdolrasoulTalaeiDepartment of SurgeryAbbasGhaderiCancer Immunology Research Group, Shiraz Institute for Cancer Research, School of Medicine, Shiraz
University of Medical Sciences, ShirazDepartment of Immunology,
School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran0000-0003-0849-3375Journal Article20160805<b>Background</b>: CCL22/MDC is a CC chemokine with a critical role in regulation of the immune balance in physiological condition. CCL22/CCR-4 ligation has been documented to participate in the migration of regulatory T (Treg) cells and Th2 lymphocytes to the site of breast tumors; circumstances that are known to be associated with poor prognosis. <br/><b>Objective</b>: To investigate the association of a single nucleotide polymorphism (SNP) in CCL22 gene; 16C/A (rs4359426; Asp2Ala), with susceptibility to breast cancer in a sample of Iranian population. <br/><b>Methods</b>: 161 patients with pathologically confirmed breast carcinoma (mean age 49.3 ± 11.5 yrs) and 178 agematched healthy women (mean age: 49.3 ± 12.9 yrs) were studied. CCL22 genotypes were investigated by the Polymerase Chain Reaction-Restriction Fragment Length Polymorphism (PCR-RFLP) method. Data was verified by direct automated sequencing. Arlequin analysis showed no deviation from Hardy-Weinberg equilibrium. <br/><b>Results</b>: The most frequent genotype in both patient and control groups was wild type CC genotype with frequency of 146 out of 161 (90.7%) among patients and 153 out of 178 (86.0%) in control group (p=0.24). The frequency of CA genotype was 15 (9.3%) and 23 (12.9%) in patients and controls, respectively (p=0.38). No AA genotype was observed among patients but this genotype was observed with the frequency of 2 out of 178 (1.1%) in control subjects. The minor allele frequency (MAF) was 0.07 in the population. <br/><b>Conclusion</b>: No correlation was found between the investigated genotypes and clinicopathological characteristics of the patients. Conclusively, results of this investigation do not support the association of 16C/A SNP (rs4359426; Asp2Ala) in CCL22 gene with susceptibility to, and progression of, breast cancer in Iranian population.Shiraz Institute for Cancer ResearchIranian Journal of Immunology1735-13839420121201Soluble CD30 in Normal Pregnancy Pre-Eclampsia and Recurrent Pregnancy Loss23424016876ENBehrouzGharesi-FardInfertility Research CenterDepartment of Immunology0000-0002-0162-3395LeilaJafarzadehDepartment of ImmunologyJalehZolghadriInfertility Research CenterDepartment of Obstetrics and Gynecology,
School of Medicine, Shiraz University of Medical Sciences, Shiraz, IranHosseinHaghbinInfertility Research CenterJournal Article20160805<b>Background</b>: Normal pregnancy is thought to be dependent on Th2 deviation, while Recurrent Pregnancy Loss (RPL) and Pre-eclampsia (PE) appear to be biased toward the Th1 immune response. It is believed that the soluble form of CD30 (sCD30) is an index of Th2 immune response or modulator of Th1/Th2 responses. <br/><b>Objective</b>: The aim of this study was determination of the sCD30 level in RPL and PE patients. <br/><b>Methods</b>: The sCD30 level was measured in sera of a group of normal non-pregnant women (N=43) and compared with normal pregnancy at the first (N=42) and third (N=42) trimester. Furthermore, the level of sCD30 in the normal first and third trimester pregnancies were compared with that of RPL (N=38) and severe pre-eclamptic (N=41) patients, respectively. sCD30 levels were measured by ELISA method and student t-test was used for statistical analysis. <br/><b>Results</b>: The mean level of sCD30 at the first trimester in normal pregnancy was significantly elevated as compared with normal non-pregnant women (21.4 vs. 15.2 ng/ml, p<0.0001). A significant difference between sCD30 concentration at the first and third trimester of normal pregnancies was also observed (21.4 vs. 14.3 ng/ml, p<0.0001). Interestingly, the sCD30 concentration did not show any significant changes at the first trimester of normal pregnancy as compared with RPL (21.4 vs. 20.9 ng/ml) and third trimester of normal pregnancy as compared with PE (14.3 vs. 13.1 ng/ml). <br/><b>Conclusion</b>: The data of this study indicated that the concentration of sCD30 in serum during pregnancy period is not associated with RPL or PE and serum sCD30 is not a good correlate of Th2 immune responses in pregnancy.Shiraz Institute for Cancer ResearchIranian Journal of Immunology1735-13839420121201Anti-Cardiolipin and Anti-Neutrophil Cytoplasmic Antibodies in Iranian Patients with Behcet's Disease24124716877ENMohammad RezaAtaollahiDepatrment of ImmunologyStudent Research CommitteeElhamAflakiDepartment of RheumatologyAutoimmune
Diseases Research CenterMohammad AliNazariniaDepartment of RheumatologyAutoimmune
Diseases Research CenterSaeedehShenavandehDepartment of RheumatologyAutoimmune
Diseases Research CenterZahraHabibagahiDepartment of RheumatologyAutoimmune
Diseases Research CenterBehrouzGharesi-FardDepatrment of ImmunologyInfertility Research Center, School of Medicine, Shiraz University of Medical
Sciences, Shiraz, Iran0000-0002-0162-3395EskandarKamali-SarvestaniDepatrment of ImmunologyAutoimmune
Diseases Research CenterJournal Article20160805<b>Background</b>: The prevalence of anti-Neutrophil Cytoplasmic Antibodies (ANCAs) and anti-Cardiolipin Antibodies (anti-CL Ab) in Behcet’s Disease (BD) and also their roles in vascular involvement is controversial. <br/><b>Objective</b>: To assess the prevalence of ANCAs and anti-CL Ab as well as their correlations with clinical manifestations in Iranian patients with BD. <br/><b>Methods</b>: In this case/control study, the sera from 88 patients with BD and 88 healthy controls were evaluated. The levels of ANCAs and anti-CL Ab were measured using indirect ELISA method. <br/><b>Results</b>: The levels of anti-CL, anti-PR3 and anti-MPO (Myeloperoxidase) IgG autoantibodies between BD patients and healthy controls were not statistically different (p=0.21, p=0.28 and p=0.74, respectively). In addition, there were no significant deferences between BD patients with and without vascular involvement in the levels of anti-CL (1.42 ± 1.24 GPLU/ml and 1.58 ± 1.18 GPLU/ml, respectively; p=0.71), anti-PR3 (0.0 ± 0.0 U/ml and 0.08 ± 0.27 U/ml, respectively; p=0.10) and anti MPO (0.48 ± 0.23 U/ml and 0.52 ± 0.22 U/ml, respectively; p=0.41) IgG autoantibodies. Nevertheless, mean titer of anti-CL IgG was higher in male patients with skin rash than those without skin rash (2.2 ± 0.88 GPLU/ml and 1.11 ± 1.22 GPLU/ml, respectively; p=0.017). <br/><b>Conclusion</b>: While anti-CL, anti- PR3 and anti-MPO IgG autoantibodies do not play a major role in susceptibility to BD or pathogenesis of vascular involvement in our patients, anti-CL Ab might be involved in skin lesion development in Iranian male BD patients. However, the results should be confirmed in other studies.Shiraz Institute for Cancer ResearchIranian Journal of Immunology1735-13839420121201Cytokine Status in Ukrainian Children with Irritable Bowel Syndrome Residing in a Radioactive Contaminated Area24825316878ENMohammad RezaSheikh SajjadiehDepartment of Clinical Immunology and Allergology, National Medical Academy for Post Graduate
EducationUkrainian Specialized Dispensaries of Radiation Defend Population, Kiev, Ukraine0000-0003-1808-6183LarisaKuznetsovaDepartment of Clinical Immunology and Allergology, National Medical Academy for Post Graduate
EducationVadimBojenkoUkrainian Specialized Dispensaries of Radiation Defend Population, Kiev, UkraineJournal Article20160805<b>Background</b>: The effect of low dose radiation on immune system is shown. Ionizing radiation can affect cytokine production and polarization of T helper cells. <br/><b>Objective</b>: The current study focused on ionizing radiation in Ukrainian children residing in a contaminated area with clinical irritable bowel syndrome. <br/><b>Method</b>: Our study included 75 rural children population aged 4-18 yrs, who lived in a contaminated area exposed to natural environmental radiation with clinical irritable bowel syndrome (categorized in three groups) and 20 rural children participants aged 5-15 yrs who were living in areas with similar levels of radioactive contamination without clinical irritable bowel syndrome as control group. Internal radiation activity was measured by gamma-ray spectrometry. Serum levels of IL-4 and IFN-γ were measured by enzyme linked immunosorbent assay. <br/><b>Results</b>: A trend towards increased levels of IL-4 was observed in children with clinical irritable bowel syndrome. In these children, IFN-γ levels were lower than that of the control group. <br/><b>Conclusion</b>: The IBS symptoms in Ukrainian children residing in a contaminated area may have stemmed from Th1 to Th2 immune deviation and differential expression of IL-4 and IFN-γ.Shiraz Institute for Cancer ResearchIranian Journal of Immunology1735-13839420121201Association of Haptoglobin Phenotypes with Serum Levels of IgE and IgA in Allergic Rhinitis Patients25426016879ENHossein AliKhazaeiDepartment of Immunology and Hematology, Cellular and Molecular Research CenterAlirezaNakhaeiDepartment of
BiochemistryGolam AliDashtiDepartment of ENTMehdiMohammadiDepartment of Health Promotion Research Center, Zahedan
University of Medical Sciences, Zahedan, IranFaribaHejazeniaDepartment of Immunology and Hematology, Cellular and Molecular Research CenterNouraMehrangeezDepartment of
BiochemistryAminKhazaeiDepartment of Immunology and Hematology, Cellular and Molecular Research CenterJournal Article20160805<b>Background</b>: Allergic rhinitis (AR) is an allergic disorder of the nasal tissue that underlies diseases such as sinusitis, otits and asthma. Different predisposing factors including immunological and non-immunological factors contribute to the disease pathogenesis. <br/><b>Objective</b>: To investigate association of haptoglobin (Hp) phenotypes (Hp1-1, 2-1 and 2-2) with serum immunoglobulins A and E levels in patients suffering from AR in comparison with healthy individuals. <br/><b>Methods</b>: Two hundred and forty patients and 240 healthy individual entered in this case-control study. Serum levels of IgE and IgA were measured and haptoglobulin phenotypes were determined by electrophoresis. The results were evaluated by χ2 statistical test using SPSS software. <br/><b>Results</b>: Serum electrophoresis showed that the distribution of haptoglobin phenotypes of Hp1-1, Hp2-1 and Hp2-2 among 240 patients were 11.3%, 37.9% and 50.8%, respectively. The distribution of different haptoglobin phenotypes in healthy controls were 88.7%, 36.6% and 54.7%, respectively. However, the difference between patients and controls was not statistically significant (p=0.136). The mean of IgE level was significantly higher in patients than controls in association with all three phenotypes (p<0.001). Mean of IgA serum level was also significantly different between case and control groups for Hp1-1 (p<0.048) and Hp2-2 phenotypes (p<0.027). <br/><b>Conclusion</b>: We conclude that there is an association of all three haptoglobin phenotypes with IgE level. Hp1-1 and Hp2-2 phenotypes showed association with IgA in allergic rhinitis, as well. However, we cannot solely attribute these associations to the pathogenesis of allergic rhinitis.Shiraz Institute for Cancer ResearchIranian Journal of Immunology1735-13839420121201Elevated Levels of Interleukin-23 in Sera of Patients with Pemphigus Vulgaris26126516880ENFirouzPouralibabaDepartment of Oral Medicine, Faculty of DentistryZohrehBabalooDepartment of Immunology, Faculty of Medicine,
Tabriz University of Medical Sciences, Tabriz, IranFarzanehPakdelDepartment of Oral Medicine, Faculty of DentistryTahmooresAbdollahianDepartment of Oral Medicine, Faculty of DentistrySolmazPourzareDepartment of Oral Medicine, Faculty of DentistryJournal Article20160805<b>Background</b>: Pemphigus vulgaris, a chronic mucocutaneous disease, is the most prevalent type of pemphigus which manifests with development of bullae and erosions on skin and mucosal membranes. <br/><b>Objectives</b>: To investigate the potential role of IL-23 in pemphigus vulgaris. <br/><b>Methods</b>: In this study, 30 patients with pemphigus vulgaris and 30 healthy individuals were selected according to inclusion and exclusion criteria. Measurement of IL-23 serum levels in blood samples was conducted by ELISA. Data was analyzed using Student’s t-test for comparison of IL-23 levels between the two groups. <br/><b>Results</b>: Mean serum levels of IL-23 in patients with pemphigus and healthy controls were 25.1 ± 4.2 and 17.9 ± 4.7 pg/ml, respectively (p<0.05). <br/><b>Conclusions</b>: Based on the findings of this study, serum levels of IL-23 were higher in patients with pemphigus in comparison to healthy individuals with no clinical significance.Shiraz Institute for Cancer ResearchIranian Journal of Immunology1735-13839420121201Comment on: Clinical, Histopathological and Immunofluorescent Findings of IgA Nephropathy26626716881ENHamidNasriDepartment of Nephrology, Division of Nephropathology, Isfahan University of Medical Sciences, Isfahan,
IranJournal Article20160805